Angela Bagley
Chief Tech/Sci/R&D Officer bij TREVENA, INC.
Profiel
Angela Bagley is currently the Vice President-Technical Operations at Trevena, Inc. Prior to her current position, she held the role of Global Head-Pharmaceutical at Bristol Myers Squibb Co. She also served as the VP-Global Supply Chain Planning & Logistics at Celgene Corp.
and as the Head-Supply Chain & Process Engineering at Merck & Co., Inc. Ms. Bagley completed her undergraduate degree at North Carolina State University.
Actieve functies van Angela Bagley
| Bedrijven | Functie | Begin |
|---|---|---|
| TREVENA, INC. | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Angela Bagley
| Bedrijven | Functie | Einde |
|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
| CELGENE | Corporate Officer/Principal | - |
Opleiding van Angela Bagley
| North Carolina State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| MERCK & CO., INC. | Health Technology |
| TREVENA, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
